🇺🇸 Transdermal Testosterone in United States

9 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Asthenopia — 1 report (11.11%)
  2. Blood Thyroid Stimulating Hormone Increased — 1 report (11.11%)
  3. Constipation — 1 report (11.11%)
  4. Dry Skin — 1 report (11.11%)
  5. Dyspnoea — 1 report (11.11%)
  6. Hypotension — 1 report (11.11%)
  7. Loss Of Consciousness — 1 report (11.11%)
  8. Onychoclasis — 1 report (11.11%)
  9. Rash — 1 report (11.11%)

Source database →

Transdermal Testosterone in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Transdermal Testosterone approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Transdermal Testosterone in United States?

University of Colorado, Denver is the originator. The local marketing authorisation holder may differ — check the official source linked above.